To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.


Already Have an Account?

Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Vol:197 Issue:1 Number:1 ISSN#:2564-2537
Author Verified
ACE Report #14313
Ace Report Cover Foot & Ankle

Prolotherapy vs. Extracorporeal Shock Wave Therapy in Chronic Plantar Fasciitis

How to Cite

OrthoEvidence. Prolotherapy vs. Extracorporeal Shock Wave Therapy in Chronic Plantar Fasciitis . ACE Report. 2022;197(1):1. Available from:

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Comparison of Ultrasound-Guided Prolotherapy Versus Extracorporeal Shock Wave Therapy in the Treatment of Chronic Plantar Fasciitis: A Randomized Clinical Trial.

J Foot Ankle Surg . Jan-Feb 2022;61(1):48-52.

Contributing Authors:
Kesikburun Serdar Şan Ayca Uran Kesikburun Bilge Aras Berke Yaşar Evren Tan Arif Kenan

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


Twenty nine patients with chronic plantar fasciitis were randomized to receive extracorporeal shockwave therapy (ESWT, n=15) or dextrose prolotherapy (n=15). Outcomes of interest included pain measured using a visual analogue scale (VAS) and function measured with the Roles and Maudsley Scale score (RMS) and the Foot Function Index (FFI). Both groups demonstrated significant improvements in pain a...

Ace Report Preview Image
CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

For Reprints and Permissions, click here

Please Login or Join to leave comments.